Aleris Group AB
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Aleris Group AB - overview
Established
1998
Location
Stockholm, -, Sweden
Primary Industry
Healthcare
About
Based in Sweden, Aleris Group AB operates as a provider of specialized medical care, focusing on personalized healthcare solutions for patients across various medical fields, ensuring accessibility and timely treatment. Aleris Group AB offers specialized medical services, primarily operating from its headquarters in Stockholm, Sweden. Founded in 1998, the company has engaged in four total deals, with the most recent deal occurring on July 12, 2019. The company was acquired by Triton Partners, who gained a majority stake from Investor and Patricia Industries.
It has raised a total of SEK 1,700. 00 mn through its latest funding round, named LP Direct. Aleris specializes in providing high-quality specialist medical care across various fields, focusing on personalized treatment options for patients seeking healthcare services. Their core offerings encompass a range of services, including consultations, diagnostics, and treatment for conditions such as eating disorders and prenatal care, including early ultrasound services.
The company operates numerous clinics throughout Sweden, catering to a diverse client base, including individual patients, families, and healthcare providers. Aleris is committed to making healthcare accessible while ensuring patients can receive expert guidance tailored to their specific health concerns without lengthy wait times. Aleris generated revenue of SEK 655,917,719. 30 in 2023, with an EBITDA of SEK 56,948,772.
70 for the same year. The company’s revenue model relies on direct patient services where individuals pay for consultations and treatments, emphasizing quality care and meeting the increasing demand for specialized medical services in Sweden. The recent investment from Triton Partners will enable Aleris Group AB to enhance its presence in the Nordic region. While specific upcoming products or services have not been detailed, the company is expected to focus on expanding its market reach and improving its service offerings to better meet patient needs in the region.
Current Investors
Investor, Triton
Primary Industry
Healthcare
Sub Industries
Home Healthcare, Nursing Homes & Assisted Living, Hospitals, Mental Health Services
Website
www.aleris.se/
Verticals
HealthTech
Company Stage
Mature
Total Amount Raised
Subscriber access only
Aleris Group AB - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Completed | Art Clinic AB | - | ||||||||
| Add-on | Completed | Proliva | - | ||||||||
| Secondary Buyout | Completed | Aleris Group AB | - | ||||||||
| Trade Sale | Completed | Aleris Group AB | - | ||||||||
| Add-on | Completed | Aleris Helse AS | - |
Displaying 1 - 5 of 12
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.